{"name": "Sarepta Therapeutics",
 "permalink": "sarepta-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/sarepta-therapeutics",
 "homepage_url": "http://www.sareptatherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "sarepta@sareptatherapeutics.com",
 "phone_number": "617-444-8424",
 "description": "",
 "created_at": "Sat Dec 15 10:51:10 UTC 2012",
 "updated_at": "Sat Dec 15 13:10:17 UTC 2012",
 "overview": "\u003Cp\u003ESarepta Therapeutics \u2013 formerly AVI BioPharma \u2013 remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta\u2019s unique technology has yielded a diverse pipeline of RNA-based therapeutics that include their lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world\u2019s most lethal infectious diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0022/5572/225572v1-max-150x150.jpg"],
     [[250,
       94],
      "assets/images/resized/0022/5572/225572v1-max-250x250.jpg"],
     [[254,
       96],
      "assets/images/resized/0022/5572/225572v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Senior Vice President, Chief Medical Officer",
    "person":
     {"first_name": "Ed",
      "last_name": "Kaye",
      "permalink": "ed-kaye",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0022/5599/225599v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5599/225599v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5599/225599v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Chris",
      "last_name": "Garabedian",
      "permalink": "chris-garabedian",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0022/5600/225600v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5600/225600v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5600/225600v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President of Technical Operations",
    "person":
     {"first_name": "Jayant",
      "last_name": "Aphale",
      "permalink": "jayant-aphale",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0022/5601/225601v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5601/225601v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0022/5601/225601v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "245 First Street",
    "address2": "Suite 1800",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Sarepta Therapeutics Announces Pricing of $125 Million Public Offering of Common Stock",
    "stoned_year": 2012,
    "stoned_month": 12,
    "stoned_day": 13,
    "source_url": "http://finance.yahoo.com/news/sarepta-therapeutics-announces-pricing-125-141456317.html",
    "source_text": "",
    "source_description": "Sarepta Therapeutics Announces Pricing of $125 Million Public Offering of Common Stock",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Sarepta Therapeutics",
      "permalink": "sarepta-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        110],
       "assets/images/resized/0022/5573/225573v1-max-150x150.jpg"],
      [[250,
        184],
       "assets/images/resized/0022/5573/225573v1-max-250x250.jpg"],
      [[450,
        332],
       "assets/images/resized/0022/5573/225573v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}